Nanogen, Inc. (NASDAQ: NGEN)

Nanogen, Inc. (NASDAQ: NGEN) is focused on developing diagnostic products that provide enhanced patient care. The company’s products are designed to offer faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These superior products include molecular diagnostic kits and reagents, as well as rapid test kits that can be utilized in urgent care settings or at the point-of-care. Nanogen is committed to bringing better results to diagnostics and healthcare. For further information, visit the Company’s web site at www.nanogen.com.